IDT Australia (IDT) Stock Price, News & Analysis

Company Overview

IDT Australia Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients (APIs) and finished dose form products in Australia and internationally. It offers analytical method development, stability chambers, chemistry and microbiology quality control laboratory, and quality assurance services. The company also provides project management, chemical, analytical chemistry, pharmacy, clinical packaging, and regulatory affairs, as well as pharmaceutical development services in various dosage forms. In addition, it offers medicinal cannabis products, as well as various contract manufacturing services. IDT Australia Limited was founded in 1975 and is headquartered in Boronia, Australia.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: $48.61 million
• P/E Ratio: N/A
• Dividend Yield: 10.67%
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: ASX
• Sector: Medical
• Industry: Drug Manufacturers - Specialty & Generic
• Sub-Industry: Communication
• Current Symbol: ASX:IDT
• CIK: N/A
• Web: www.idtaus.com.au
• Phone: 61 3 9801 8888
• Fax: N/A
• Employees: 1,690
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): A($0.02)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-5,410,000.00
• Net Margins: -38.61%
• Pretax Margin: N/A
• Return on Equity: -23.28%
• Return on Assets: -12.69%

Debt

• Debt-to-Equity Ratio: 19.06
• Current Ratio: 1.34
• Quick Ratio: 4.15

Sales & Book Value

• Annual Sales: $14.02 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: A$0.07 per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 429,840,000
• Free Float: N/A
• Market Cap: $48.61 million
• Optionable: Not Optionable
• Beta: 1.22